- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Winners of ARVO/Pfizer translational research awards announced
Joan W. Miller, MD, and Joel S. Schuman, MD, are the winners of the2006 ARVO/Pfizer Ophthalmics Translational Research Awards.
Joan W. Miller, MD, and Joel S. Schuman, MD, are the winners of the 2006 ARVO/Pfizer Ophthalmics Translational Research Awards.
Dr. Miller, of the Massachusetts Eye and Ear Infirmary, Boston, was honored for research in non-human primates and resulting translation to humans. This led to the development of photodynamic therapy of neovascular age-related macular degeneration.
Dr. Schuman, University of Pittsburgh, was recognized as a key researcher in the development of optical coherence tomography, which has widespread clinical application in the diagnosis and management of glaucoma and retinal diseases.
The awards were established with the intent of honoring excellence in research and fundamental scientific discoveries, concepts, and novel technologies that lead to clinical evidence of diagnosis, prevention, or amelioration of the pathological eye and/or understanding of normal vision processes. The translational research awards are made possible through a grant from Pfizer Ophthalmics to The ARVO Foundation for Eye Research.
